Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
EpiVax Announces Licensing of a COVID-19 Vaccine Candidate to EpiVax Therapeutics
Wednesday, August 26, 2020EpiVax Inc a Rhode Island based company known as a leader in the computational vaccination industry announced that it has acquired a Licensed a vaccine candidate against COVID under the identifier EPVCoV to EpiVax Therapeutics EVT a New York based co...
Engitix Signs Collaboration and Licensing Agreement with Takeda to Develop Anti-Fibrotic Therapies in Advanced Liver Diseases
Wednesday, August 26, 2020Engitix Ltd Engitix a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix ECM platform entered into a licensing and collaboration agreement with Takeda Pharmaceutic...
HitGen and Almirall Announce Achievement of Milestone in Their Strategic Collaboration
Wednesday, August 26, 2020HitGen Inc announced that the company has achieved a milestone in their strategic collaboration with Almirall to develop a novel class of drugs The licensed compounds were identified using HitGens leading technology platform which involved screening...
Harbour BioMed Signs Strategic Collaboration Agreement with Vir Biotechnology to Develop Novel Therapies for Immuno-Oncology and Infectious Diseases
Tuesday, August 25, 2020Harbour BioMed HBM a global clinicalstage biopharmaceutical company announced that it has entered into a strategic collaboration with Vir Biotechnology Nasdaq VIR a clinicalstage immunology company to discover develop and commercialize potential nove...
Bio-Thera Solutions and BeiGene Announce License, Distribution, and Supply Agreement for Avastin® (Bevacizumab) Biosimilar BAT1706 in China
Tuesday, August 25, 2020BioThera Solutions Ltd a commercial stage biopharmaceutical company SH and BeiGene Ltd announced that the companies have executed a license distribution and supply agreement for China for BioTheras BAT an investigational biosimilar to Avastin bevaciz...
AbbVie, Harvard University Form Research Alliance to Address Emergent Viral Diseases
Tuesday, August 25, 2020AbbVie and Harvard University today announced a million collaborative research alliance launching a multipronged effort at Harvard Medical School HMS to study and develop novel therapies against emergent viral infections with a focus on those caused...
SAB Biotherapeutics Announces SAB-185 to First Patient Treatment for COVID-19 in Phase 1b Clinical Trial
Monday, August 24, 2020SAB Biotherapeutics a clinicalstage biopharmaceutical company developing a novel immunotherapy platform for the production of targeted polyclonal antibodies today announced the administration of SAB to the first patient as part of its phase b clinica...
RenalytixAI to Collaborate with AstraZeneca to Improve Outcomes for Patients with Chronic Disease
Monday, August 24, 2020Renalytix AI plcannounced a collaboration with AstraZenecato develop and launch precision medicine strategies for cardiovascular renal and metabolic diseases The first stage in the collaboration will use KidneyIntelX an artificial intelligenceenabled...
Junshi Biosciences and Impact Therapeutics Establish Joint Venture to Develop PARP Inhibitor Senaparib (IMP4297) in China
Friday, August 21, 2020Junshi Biosciences a leading innovationdriven biopharmaceutical company dedicated to the discovery development and commercialization of novel therapies and Impact Therapeutics a privately held clinicalstage biopharmaceutical company devoted to the di...
Sorrento Enters Into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies
Friday, August 21, 2020Sorrento Therapeutics Inc and SmartPharm Therapeutics Inc SmartPharm announced the signing of a merger agreement under which Sorrento will acquire SmartPharm a geneencoded therapeutics company developing nonviral DNA and RNA gene delivery platforms f...
